Gilead's Cayston Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study - Drugs.com MedNews
Links shared publicly online about this topic.
- 785total visits
Gilead's Cayston Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study - Drugs.com MedNews
Oct 21, 2010 - Gilead Sciences, Inc. (Nasdaq GILD) today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution)
View full resource at drugs.com
Tags: Cystic Fibrosis, Drug, Clinical Trial, Gilead Sciences, Gilead Sciences Inc., Science
Most Recently Shared on October 21, 2010 at 8:16 pm By:
Gilead's Cayston Superior to Tobramycin Inhalation Solution in Six-Month Head-to-Head Cystic Fibrosis Study: ... http://bit.ly/bsQH99 #drug
Advertisement
